Market Leadership Through customer loyalty with prominent brand identity, living improvement culture and evergreen leaders
Enabling anticipative, accurate & convenient health care for better life
PTHI Symposium 2015
EMP participated in the Symposium 'Update on Thrombosis & Hemostasis In 2015'
On 6-7 March 2015, the Association of Indonesian Thrombosis (PTHI) annual meeting held in 2015 with the theme of 'Update on Thrombosis & Hemostasis In 2015' and chaired by Dr. dr. Lugyanti Sukrisman, Sp.PD, K-HOM. The two-day symposium involving various disciplines of medicine, including internal medicine, hematology, obstetrics and gynecology, eye, vascular surgery, orthopedics, cardiovascular, radiology, and neuroscience.
EMP participated in a symposium this time through a symposium held on the 2nd day (March 7, 2015) with invited speakers who are experts in the field of Venous Thromboembolism (VTE) among others: Prof. dr. Faith Supandiman, Sp.PD, K-HOM (Moderator), Prof. Dr dr. Carmel L. Tambunan, Sp.PD, K-HOM (Speaker of Diagnostic Approach of VTE), Prof. dr. Rahajuningsih D. Setiabudy, Sp.PK, DSc (Speaker of Laboratory Test to Exclusion of VTE), Dr. dr. Lugyanti Sukrisman, Sp.PD, K-HOM (Speaker of Management of VTE).
Also attending the event, Mrs. Rita Meuraksa (PM Hoslab), Hoslab Biomerieux Jabodetabek sales force team, dr. Sujitno Fadli (Head of SCM - Scientific), dr. Irwan Widjaja (Scientific Support), dr. Dicky Teguh S (Scientific Support), Mr. Lukas (Country Manager of Biomerieux Indonesia), Dra. Yuni Astuti (Business Manager Clinical of Biomerieux Indonesia), and Mr. Oyon (Biomerieux Indonesia).
VTE is a silent killer that should be concerned at because it is a major cause of death in United States, Europe and other parts of the world. In various surgery also has a risk of VTE in patients. VTE is the main base of thrombosis. Thrombosis is a blood vessel coagulation in excessive thereby inhibiting the flow of blood, or even stop the flow.
Thrombosis can occur anywhere in the human blood circulation. One type of thrombosis that may occur in the veins is deep vein thrombosis (DVT), usually these symptoms accompanied by an embolus that regardless of the pulmonary vessels and circulate in the blood circulation to reach the veins are generally located on the feet.
Therefore, VTE is a term used to describe symptoms of complications of deep vein thrombosis (DVT) and pulmonary embolism ( PE ).
Biomerieux VIDAS has a superior parameter in the diagnosis of VTE problem quickly and safely get rid of patients who do not require treatment (patients without VTE) VIDAS D-Dimer Exclusion II (The First US FDA Approval) has a level of sensitivity and Negative Predictive Value approaching perfect.
Therefore multi-disciplinary approach and the use of Vidas D-Dimer Exclusion II that used combined with Pre-Test Clinical Probability (PTP) Well"s Score & Revised Geneva Score, expected preventive steps and treatment of VTE problem could be better in the near future.
( Reported by Dicky Teguh S., MD – EMP Scientific Support )